DIFLORASONE DIACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Diflorasone Diacetate, and what generic alternatives are available?
Diflorasone Diacetate is a drug marketed by Ani Pharms, Avondale Pharms, Taro, Rising, Sciegen Pharms Inc, and The J Molner. and is included in eight NDAs.
The generic ingredient in DIFLORASONE DIACETATE is diflorasone diacetate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the diflorasone diacetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diflorasone Diacetate
A generic version of DIFLORASONE DIACETATE was approved as diflorasone diacetate by AVONDALE PHARMS on April 27th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DIFLORASONE DIACETATE?
- What are the global sales for DIFLORASONE DIACETATE?
- What is Average Wholesale Price for DIFLORASONE DIACETATE?
Summary for DIFLORASONE DIACETATE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Patent Applications: | 6,205 |
Drug Prices: | Drug price information for DIFLORASONE DIACETATE |
DailyMed Link: | DIFLORASONE DIACETATE at DailyMed |
Pharmacology for DIFLORASONE DIACETATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |